Aptamer Group (APTA)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.51p
   
  • Change Today:
    -0.043p
  • 52 Week High: 25.50
  • 52 Week Low: 0.50
  • Currency: UK Pounds
  • Shares Issued: 467.34m
  • Volume: 2,090,833
  • Market Cap: £2.37m

Aptamer secures two contracts with big pharma firm

By Josh White

Date: Thursday 17 Aug 2023

LONDON (ShareCast) - (Sharecast News) - Life sciences company Aptamer Group has secured two new contracts with one of the world's top five pharmaceutical companies, it announced on Thursday, with an estimated worth of up to £0.22m.
The AIM-traded firm said the contracts showcased a continuation of its commitment to its previously-announced sales pipeline.

It said the revenue recognition for the newly-acquired contracts would, however, hinge on the scientific and commercial outcomes as they progressed.

Completion was expected within the current fiscal year.

The company said the first contract revolved around the formulation of an Optimer pair tailored for a neurodegenerative biomarker, intended for deployment on an immunoassay platform.

It said the subsequent contract, building on prior successes, would involve the concluding phase of Optimer development targeting a neuronal protein.

That would be for application in immunohistochemistry (IHC), and would come after achieving encouraging results during the earlier Optimer development phases.

"I am pleased to be able to extend our partnership with this top five pharma partner," said chief executive officer Dr Rob Quinn.

"These two projects are further evidence of the need for Optimer binders to meet challenging requirements for use in real-world applications when, to date, antibodies have been unable to provide a satisfactory solution, such as IHC.

"Building awareness and adoption of Optimer technology by such partners is key to allowing us to deliver on our strategy of executing therapeutic, diagnostic, and bioprocessing licensing deals."

At 1605 BST, shares in Aptamer Group were down 27.57% at 1.34p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Aptamer Group Market Data

Currency UK Pounds
Share Price 0.51p
Change Today -0.043p
% Change -7.85 %
52 Week High 25.50
52 Week Low 0.50
Volume 2,090,833
Shares Issued 467.34m
Market Cap £2.37m

Aptamer Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
60.5% below the market average60.5% below the market average60.5% below the market average60.5% below the market average60.5% below the market average
81.13% below the sector average81.13% below the sector average81.13% below the sector average81.13% below the sector average81.13% below the sector average
Price Trend
97.71% below the market average97.71% below the market average97.71% below the market average97.71% below the market average97.71% below the market average
89.47% below the sector average89.47% below the sector average89.47% below the sector average89.47% below the sector average89.47% below the sector average
Income Not Available
Growth
12.11% below the market average12.11% below the market average12.11% below the market average12.11% below the market average12.11% below the market average
18.92% below the sector average18.92% below the sector average18.92% below the sector average18.92% below the sector average18.92% below the sector average

Aptamer Group Dividends

No dividends found

Trades for 15-Apr-2024

Time Volume / Share Price
09:34 40,833 @ 0.54p
09:09 150,000 @ 0.55p
09:03 900,000 @ 0.51p
08:44 1,000,000 @ 0.52p

Top of Page